Filing Details

Accession Number:
0001735276-24-000072
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-27 16:04:53
Reporting Period:
2024-06-25
Accepted Time:
2024-06-27 16:04:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178670 Alnylam Pharmaceuticals Inc. ALNY Pharmaceutical Preparations (2834) 770602661
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1438226 W Amy Schulman 675 West Kendall Street
Henri A. Termeer Square
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-06-25 8,500 $131.21 16,936 No 4 M Direct
Common Stock Disposition 2024-06-25 8,500 $240.00 8,436 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2024-06-25 8,500 $0.00 8,500 $131.21
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,750 2016-06-01 2025-06-01 No 4 M Direct
Footnotes
  1. All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on February 28, 2024.
  2. This stock option was fully vested and exercisable as of June 1, 2016.